Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome